The Drugreporter Podcast

Rights Reporter Foundation
  • 0.0 (0)
  • Politics
  • Updated Daily

The Drug Policy podcast of the Rights Reporter Foundation. Visit https://www.drugreporter.net for news and films from the frontlines of the war on drugs!

  1. 3h ago

    ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

    At ICPR 2024, we talked to Robert Jesse, from the Johns Hopkins University, about mystical experiences with psychedelics, their spiritual and cultural dimensions, and the value of community in supporting their responsible integration. Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

  2. 3h ago

    LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

    At ICPR 2024, we talked to Leonie Schneider and Ian Roullier, co-founders and co-directors of the Psychedelic Participant Advocacy Network (PsyPAN) in the UK, about why patient voices matter in the development of psychedelic therapy. Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

  3. 3h ago

    Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

    Psychedelic research in the Czech Republic has a long and distinguished history. At ICPR 2026, we spoke with psychiatrist and neuroscientist Tomáš Páleníček about clinical research, altered states of consciousness, innovative therapeutic approaches, and the future of psychedelic science in Europe and beyond. Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

  4. Aug 31

    WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

    At ICPR 2024, we talked to Wim van den Brink, MD, PhD, Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam, about the potential of psychedelics to reduce compulsive thinking and support addiction treatment. Chapters: 00:00 Intro 00:05 How did you get involved as a researcher in studying psychedelics? 01:24 Some people say that psychedelics are one of the first new major innovations since the 70s in Psychiatry. How do you see that? 03:07 Psychedelic treatment is a hybrid between talking therapy and psychopharmacological treatment. How is it different from traditional forms of treatment? 05:53 What is the neuro biological mechanism that explains why psychedelics are so effective in treatment? 10:16 Psychedelics don't work for everyone. Do we have any idea for whom they work and for whom they don't work? 13:45 Do psychedelics have a potential to treat addiction? 16:05 Clinical treatment has very strict rules and limitations. But people have been using psychedelics in other non-medical settings in groups, in the nature. Do you think that we can combine those methods with clinical treatment?   17:53 Some people say that we move too fast. And, there is, risk of, backlash. How do you see that risk? 18:55 You talked about retreats. As far as I know there are many retreats in the Netherlands. How are they regulated?  20:48 What is the situation with MDMA treatment in the Netherlands?  22:06 The costs of psychedelic treatment are very high. How can we make sure that they are accessible to less wealthy people as well?  24:20 How do you see the role of harm reduction in the psychedelic field?  26:09 How do you see the future of psychedelics? Will they be part of the mainstream medical care? And do they have room outside of the medical realm?  Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

  5. Aug 31

    Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

    What actually makes psychedelic therapy work? Is it the drug, the therapeutic setting, or the human relationship between therapist and participant? At ICPR 2026, we spoke with psychiatrist and researcher Sandeep Nayak about clinical trials, common therapeutic factors, and how the field can better understand the mechanisms behind psychedelic-assisted treatment. Chapters: 00:00 Intro 00:29 Could you introduce yourself? 01:33 Is psychedelic therapy a major pharmacological innovation? 02:12 Will psychedelic therapy become mainstream? 03:06 What is evidence and what is hype? 04:02 Where do psychedelics seem to work? 05:15 How do you see the FDA decision on MDMA? 07:15 What are the main methodological problems? 08:59 How do you see the psychedelic renaissance now? 11:02 Can researchers impose cultural values on participants? 12:43 What research questions matter most now? 15:05 Which theory of psychedelic action do you favor? 17:33 Can microdosing be effective? 19:01 Can the drug effect be separated from the experience? 20:25 Can you share a memorable patient story? 23:28 What is the potential for treating addiction? 26:04 What other conditions could psychedelics help? 27:19 Could group therapy reduce costs? 28:24 How do you see political support from pseudoscientific voices? Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

  6. Aug 31

    NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

    At ICPR 2024, we talked to anthropologist and author Nicolas Langlitz about the current hype around psychedelics, their place in medicine and culture, and why he sees them as holding the promise of moksha in the age of soma. Chapters: 00:00 Intro 00:05 Nicholas, can you talk about your professional background? 01:32 Some people say they are moving too fast. And there is an overhype of psychedelics. What do you think about that? 05:15 In your book, you write that psychedelics have the promise of moksha in the age of soma. 08:57 It seems nowadays the psychedelic movement has less ambitions, than in the 60s. So they don’t want to change the world, they just want to medicalize these substances. 11:17 Can we make psychedelics a standardized medical treatment? They come with so much spiritual and metaphysical baggage. 13:21 Unlike traditional antidepressants, in the case of psychedelics, it is very important in what environment you use drugs and in what mental states. Can you explain us the role of set and setting? 18:58 Some people would keep psychedelics under strict medical supervision. But do you think there is a room for psychedelics outside of the medical realm? 22:24 Is there no alternative to the biomedical model? 24:49 Timothy Leary has another idea about training people how to use psychedelics and giving out licenses such as driving licenses. That could be a secularized model to regulate these substances. What do you think? Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

  7. Aug 31

    Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

    Women make up more than half of the population, yet they remain significantly underrepresented in psychedelic research. At ICPR 2026, we spoke with neuroscientist Grace Blest-Hopley about the gender gap in psychedelic science, the importance of studying menstrual cycles, pregnancy, menopause, and women’s mental health, and how the field can become more inclusive and scientifically rigorous. Chapters 00:00 Intro 00:30 Could you introduce yourself? 02:56 Why are military and psychedelic research male-dominated? 06:08 How do gender differences appear in psychedelic trials? 07:31 How do biology and hormones shape psychedelic experiences? 11:18 Do trial designers understand these gender differences? 12:45 Do women and men report psychedelic experiences differently? 15:48 Could psychedelics help with postpartum depression or menopause? 21:15 What are the key frontiers for future research? 24:14 What is Hystelica and what are its goals? 26:57 Do you meet resistance or openness in academia? 29:44 Could future clinics focus on menopause or women’s health? Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

  8. May 26

    MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

    At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance of integration in psychedelic therapy. Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

    MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes
See All (123)

About

The Drug Policy podcast of the Rights Reporter Foundation. Visit https://www.drugreporter.net for news and films from the frontlines of the war on drugs!

Information

  • Creator
    Rights Reporter Foundation
  • Years Active
    2020 - 2026
  • Episodes
    123
  • Rating
    Clean
  • Copyright
    © Rights Reporter Foundation
  • Show Website
    The Drugreporter Podcast